HAS2 and cancer: The Has2-deficient Has2Δ/Δ cancer cells displayed greatly reduced Akt phosphorylation at both Ser473 and Thr308 as well as GSK3β phosphorylation at Ser9 as compared with control Has2flox/flox cells (Fig. 4a, b).